HOME >> MEDICINE >> NEWS
Oregon Health Sciences University Researcher Presents Results Of Clinical Trials Of Possible Stroke-Fighting Drug

Results of citicoline trial to be presented this week at annual American Heart Association Stroke Conference

A stroke-fighting drug up for possible approval by the U.S. Food and Drug Administration showed mixed results in a nationwide clinical trial, according to research being presented this Saturday, February 7, at the annual American Heart Association Stroke and Circulation Conference in Orlando, Florida. Wayne Clark, M.D., associate professor of neurology, and director of the Oregon Stroke Center at Oregon Health Sciences University, was lead researcher in a multicenter clinical trial of citicoline. Citicoline, manufactured under the brand name Ceraxon (TM) by Massachussetts-based Interneuron Pharmaceuticals Inc. has shown promise of reducing stroke-related injury by stablizing cell membranes long enough to prevent large-scale brain cell damage after stroke.

The clinical trial, involving nearly 400 patients in 33 centers nationwide, showed no statistically significant difference in five areas--including full recovery and mortality rates, neurological and cognitive function--between patients with stroke who were given citicoline, and those who were given a placebo. "However, the drug did appear to produce an improvement over placebo in a subset of patients with moderate to severe strokes," said Clark. Patients were first given the drug or a placebo within a few hours of their stroke, then for six weeks afterward, with a six-week, post-treatment follow-up period. Interneuron submitted a New Drug Application for citicoline to the FDA in December. The drug is already being marketed in approximately 30 countries.

Clark is scheduled to present the results of the clinical trial on Saturday, February 7, 1998 at the Omni Rosen Hotel in Orlando, Florida. Call Henry Sessions at (503) 494-8231 if you wish to speak with Clark before the presentation.


'"/>

Contact: Henry Sessions
sessionh@ohsu.edu
(503) 494-8231
Oregon Health & Science University
7-Feb-1998


Page: 1

Related medicine news :

1. Micro nano breakthrough conference planned for Portland, Oregon
2. OHSU researcher co-authors National State-By-State Report Card on women and smoking; Oregon flunks
3. Oregon State chemist wins national award for synthesizing molecules in nature
4. Oregon Health Sciences University Researchers track long-term results of chemotherapy assisted by blood-brain barrier disruption
5. Oregon Health Sciences University researchers study benefits of treatments offered within hours of a stroke
6. Lower death rate in Oregon hospitals linked to better care
7. One of first bone marrow transplants for juvenile rheumatoid arthritis in the United States is approved for Oregon girl
8. 12-year-old Oregon girl is first child to receive new bone growth material in her skull
9. Oregon Health Sciences University, Portland, Oregon receives $6.5 million to fund studies on health of adolescents and firefighters
10. Oregons Terminally Ill Patients More Likely to Have End-Of-Life Choices Respected, Study Finds
11. Mailman School of Public Health receives Manhattan Tobacco Cessation Center grant

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/3/2020)... ... September 03, 2020 , ... The American Medical Spa ... April 7, to Saturday, April 10, 2021, at Wynn Las Vegas. The event ... national trade show for non-invasive medical aesthetic practices that brings together owners, physicians, ...
(Date:9/1/2020)... ... September 01, 2020 , ... ... completed $3 million convertible note financing, which will be used to accelerate the ... funds from this financing, the company will continue to expand its customer base ...
(Date:8/31/2020)... YORK (PRWEB) , ... August 31, 2020 , ... ... nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving ... patient services – today announced the 10th Anniversary of Blood Cancer Awareness Month ...
(Date:8/31/2020)... AURORA, Colo. (PRWEB) , ... August 31, 2020 ... ... premier provider of innovative higher-learning opportunities through high-quality, career-relevant, and affordable online education ... Emergency Responder Psychology . , Among the first of its kind in ...
(Date:8/31/2020)... ... 2020 , ... Dr. Chang has over 20 years of ... developmental disabilities, as well as supporting staff in caring for patients and families. ... and staff development. She joined the company in 2015 as Chief of Clinical ...
Breaking Medicine News(10 mins):
(Date:9/3/2020)... , ... September 03, 2020 , ... ... Cell Awareness Month in September by holding a series of events and supporting ... Congress to focus attention on the need for research and treatment of sickle ...
(Date:9/3/2020)... ... September 03, 2020 , ... Q&J Face Masks announced today ... aerosol and engineering lab, conducted tests on Q&J’s personal face mask that indicated ... many other masks. Q&J face masks have both mechanical filtering and electrostatic filtering ...
(Date:9/3/2020)... ... September 03, 2020 , ... Using Analysis of Variance — A Practical ... 2020, 1:30 p.m.-3:00 p.m. EDT, https://www.fdanews.com/anova , How much would it help ... one can’t become one in 90 minutes, one can master a powerful statistical technique ...
Breaking Medicine Technology:
Cached News: